Zhimin Tong, Ph.D. - Publications

Affiliations: 
2002 McMaster University, Hamilton, ON, Canada 
Area:
Molecular Biology, Oncology

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Tong Z, Chatterjee D, Deng D, Veeranki O, Mejia A, Ajani JA, Hofstetter W, Lin S, Guha S, Kopetz S, Krishnan S, Maru D. Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma. Oncotarget. PMID 28404924 DOI: 10.18632/Oncotarget.15645  0.436
2012 Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB. Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets International Journal of Cancer. 131: E292-E303. PMID 21935918 DOI: 10.1002/Ijc.26442  0.322
2011 Tong Z, Chakraborty S, Sung B, Koolwal P, Kaur S, Aggarwal BB, Mani SA, Bresalier RS, Batra SK, Guha S. Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells. Cancer. 117: 2408-18. PMID 24048788 DOI: 10.1002/Cncr.25803  0.311
2011 Ochi N, Tanasanvimon S, Matsuo Y, Tong Z, Sung B, Aggarwal BB, Sinnett-Smith J, Rozengurt E, Guha S. Protein kinase D1 promotes anchorage-independent growth, invasion, and angiogenesis by human pancreatic cancer cells. Journal of Cellular Physiology. 226: 1074-81. PMID 20857418 DOI: 10.1002/Jcp.22421  0.48
2010 Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Yadav VR, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB. γ-Tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment Cancer Research. 70: 8695-8705. PMID 20864511 DOI: 10.1158/0008-5472.Can-10-2318  0.349
2010 Harikumar KB, Kunnumakkara AB, Ochi N, Tong Z, Deorukhkar A, Sung B, Kelland L, Jamieson S, Sutherland R, Raynham T, Charles M, Bagherzadeh A, Bagherazadeh A, Foxton C, Boakes A, et al. A novel small-molecule inhibitor of protein kinase D blocks pancreatic cancer growth in vitro and in vivo. Molecular Cancer Therapeutics. 9: 1136-46. PMID 20442301 DOI: 10.1158/1535-7163.Mct-09-1145  0.305
2009 Matsuo Y, Raimondo M, Woodward TA, Wallace MB, Gill KR, Tong Z, Burdick MD, Yang Z, Strieter RM, Hoffman RM, Guha S. CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer. International Journal of Cancer. Journal International Du Cancer. 125: 1027-37. PMID 19431209 DOI: 10.1002/Ijc.24383  0.434
2009 Matsuo Y, Ochi N, Sawai H, Yasuda A, Takahashi H, Funahashi H, Takeyama H, Tong Z, Guha S. CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer. International Journal of Cancer. 124: 853-61. PMID 19035451 DOI: 10.1002/Ijc.24040  0.365
2008 Tong Z, Kunnumakkara AB, Wang H, Matsuo Y, Diagaradjane P, Harikumar KB, Ramachandran V, Sung B, Chakraborty A, Bresalier RS, Logsdon C, Aggarwal BB, Krishnan S, Guha S. Neutrophil gelatinase-associated lipocalin: A novel suppressor of invasion and angiogenesis in pancreatic cancer Cancer Research. 68: 6100-6108. PMID 18676832 DOI: 10.1158/0008-5472.Can-08-0540  0.471
2006 Tong Z, Wu X, Chen CS, Kehrer JP. Cytotoxicity of a non-cyclooxygenase-2 inhibitory derivative of celecoxib in non-small-cell lung cancer A549 cells. Lung Cancer (Amsterdam, Netherlands). 52: 117-24. PMID 16497409 DOI: 10.1016/J.Lungcan.2005.12.003  0.408
2005 Tong Z, Wu X, Ovcharenko D, Zhu J, Chen CS, Kehrer JP. Neutrophil gelatinase-associated lipocalin as a survival factor. The Biochemical Journal. 391: 441-8. PMID 16060857 DOI: 10.1042/Bj20051020  0.53
2003 Tong Z, Singh G, Valerie K, Rainbow AJ. Activation of the stress-activated JNK and p38 MAP kinases in human cells by Photofrin-mediated photodynamic therapy. Journal of Photochemistry and Photobiology. B, Biology. 71: 77-85. PMID 14705642 DOI: 10.1016/J.Jphotobiol.2003.08.001  0.609
2003 Tong Z, Wu X, Kehrer JP. Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886. The Biochemical Journal. 372: 203-10. PMID 12614196 DOI: 10.1042/Bj20021696  0.4
2002 Tong Z, Singh G, Rainbow AJ. Sustained activation of the extracellular signal-regulated kinase pathway protects cells from photofrin-mediated photodynamic therapy. Cancer Research. 62: 5528-35. PMID 12359764  0.582
2001 Tong Z, Singh G, Rainbow AJ. Extreme dark cytotoxicity of Nile Blue A in normal human fibroblasts. Photochemistry and Photobiology. 74: 707-11. PMID 11723799 DOI: 10.1562/0031-8655(2001)074<0707:Edconb>2.0.Co;2  0.575
2000 Tong Z, Singh G, Rainbow AJ. The role of the p53 tumor suppressor in the response of human cells to photofrin-mediated photodynamic therapy. Photochemistry and Photobiology. 71: 201-10. PMID 10687395 DOI: 10.1562/0031-8655(2000)071<0201:Trotpt>2.0.Co;2  0.631
Show low-probability matches.